Kiromic BioPharma Reports Third Quarter 2020 Financial Results and Continued Corporate Progress
HOUSTON–(BUSINESS WIRE)–Nov 30, 2020– Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a pre-clinical stage biotechnology company
HOUSTON–(BUSINESS WIRE)–Nov 30, 2020– Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a pre-clinical stage biotechnology company